Activation of Skeletal Muscle AMPK Promotes Glucose Disposal and Glucose Lowering in Non-human Primates and Mice.
Cokorinos, E.C., Delmore, J., Reyes, A.R., Albuquerque, B., Kjbsted, R., Jrgensen, N.O., Tran, J.L., Jatkar, A., Cialdea, K., Esquejo, R.M., Meissen, J., Calabrese, M.F., Cordes, J., Moccia, R., Tess, D., Salatto, C.T., Coskran, T.M., Opsahl, A.C., Flynn, D., Blatnik, M., Li, W., Kindt, E., Foretz, M., Viollet, B., Ward, J., Kurumbail, R.G., Kalgutkar, A.S., Wojtaszewski, J.F.P., Cameron, K.O., Miller, R.A.(2017) Cell Metab 25: 1147-1159.e10
- PubMed: 28467931 
- DOI: 10.1016/j.cmet.2017.04.010
- Primary Citation of Related Structures:  
5UFU - PubMed Abstract: 
The AMP-activated protein kinase (AMPK) is a potential therapeutic target for metabolic diseases based on its reported actions in the liver and skeletal muscle. We evaluated two distinct direct activators of AMPK: a non-selective activator of all AMPK complexes, PF-739, and an activator selective for AMPK β1-containing complexes, PF-249 ...